Literature DB >> 24091313

Intranasal immunization with a non-adjuvanted adhesive protein descended from Pasteurella pneumotropica and its preventive efficacy against opportunistic infection in mice.

Hiraku Sasaki1, Hiroki Ishikawa, Ken Kojima, Masahiro Itoh, Tetsuya Matsumoto, Takumi Itoh, Osamu Hosomi, Eiichi Kawamoto.   

Abstract

Intranasal vaccination is one of the most effective means of protecting against invading and colonizing pathogens because the vaccine elicits a mucosal immune response. The exploitation of vaccine adjuvants and delivery systems for intranasal vaccines is an important way to evoke antigen immunogenicity and elicit a better immune response at the mucosal sites. In the present study, we assessed the potential of intranasal immunization using a non-adjuvanted bacterial adhesive protein toward the host organs. We evaluated intranasal immunization with modified recombinant PnxIIIA (MP3) from Pasteurella pneumotropica and its preventive efficacy against opportunistic infection caused by P. pneumotropica, without using any adjuvants or delivery systems. The 100-kDa MP3 was confirmed to retain its immunogenicity and binding activity to collagen type I similar to the parent PnxIIIA. When MP3 was fused to green-fluorescent protein and inoculated into C57BL/6J mice intranasally, fluorescence intensity in the intranasal airway could be observed until 3 h after inoculation. Mice were intranasally immunized with MP3 at a maximum of 4 doses, with 7-day intervals. The antibody titer of serum IgG and IgA specific for MP3, as well as that of bronchoalveolar lavage fluid IgA, showed more than 9 (log₂) after 3 or 4 rounds of immunization. Experimentally infecting immunized mice with P. pneumotropica resulted in the inability to isolate the bacterium from the nasal cavity, trachea, conjunctiva, or cecum with more than 3 doses in the immunized mice. Although the detection in each organ seldom changed with less than 2 rounds of immunization, unlike that observed in the non-immunized mice, the detection remarkably decreased with 3 or more rounds of immunization. These results suggest that intranasal immunization with a non-adjuvanted adhesive protein could have preventive effects against opportunistic infection by P. pneumotropica.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AG; Adhesive protein; Intranasal immunization; MP3; Opportunistic infection; Pasteurella pneumotropica; green-fluorescent protein Azami-Green; modified recombinant PnxIIIA protein; rPnxIIIA; recombinant PnxIIIA protein

Mesh:

Substances:

Year:  2013        PMID: 24091313     DOI: 10.1016/j.vaccine.2013.09.033

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Characterization of Biofilm Formation in [Pasteurella] pneumotropica and [Actinobacillus] muris Isolates of Mouse Origin.

Authors:  Martin Sager; W Peter M Benten; Eva Engelhardt; Christina Gougoula; Laurentiu Benga
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240

2.  Comparative analysis of humoral immune responses and pathologies of BALB/c and C57BL/6 wildtype mice experimentally infected with a highly virulent Rodentibacter pneumotropicus (Pasteurella pneumotropica) strain.

Authors:  Juliane Fornefett; Jaqueline Krause; Kristin Klose; Felix Fingas; Rayk Hassert; Laurentiu Benga; Thomas Grunwald; Uwe Müller; Wieland Schrödl; Christoph Georg Baums
Journal:  BMC Microbiol       Date:  2018-05-30       Impact factor: 3.605

3.  Sensitive and immunogen-specific serological detection of Rodentibacter pneumotropicus infections in mice.

Authors:  Felix Fingas; Daniela Volke; Rayk Hassert; Juliane Fornefett; Sophie Funk; Christoph Georg Baums; Ralf Hoffmann
Journal:  BMC Microbiol       Date:  2019-02-18       Impact factor: 3.605

4.  Draft Genome Sequence of the Rodent Opportunistic Pathogen Pasteurella pneumotropica ATCC 35149T.

Authors:  Hiraku Sasaki; Hiroki Ishikawa; Ryoki Asano; Hidehiro Ueshiba; Tetsuya Matsumoto; Ron Boot; Eiichi Kawamoto
Journal:  Genome Announc       Date:  2014-08-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.